NCI-H292 In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-0123-YF1677
Target Cell Organism: Human
Target Cell Alternative Name: H292
Target Cell Name: NCI-H292
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide NCI-H292-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H292
Target Cell Organism
Human
Target Cell Background
This line was derived from a lymph node metastasis of a pulmonary mucoepidermoid carcinoma. The cells were isolated in a chemically defined medium (HITES) and later adapted to growth in media supplemented with serum.
Target Cell Alternative Name
H292
Related Diseases
Lung Cancer
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry